Moderna’s Consolidated Vaccine for COVID-19 and Influenza
Hughes is quoted as saying that vaccines against COVID and flu could be made available by winter 2023.
Last year, the NHS sought to reassure patients that taking flu and COVID shots at the same time did not affect the immune response.
Moderna is also currently developing a vaccine to specifically deal with the Omicron variant. Early-stage data on its effectiveness is expected within the next two weeks.
Moderna also hopes to create a drug against COVID, influenza, and respiratory syncytial virus (RSV), which often causes mild but can be severe symptoms, especially for infants and older adults. , in the winter of 2024, the report said.
“Our #1 priority for 2022, after the right COVID vaccine for the Omicron variant, is to try and really leverage our influenza and RSV programs to see if we can get get a single-dose respiratory vaccine,” Hughes said.
“It would be great for the patients if you could get an appointment – come along, take that stab and you’re protected against all winter serious respiratory illnesses.”
Hughes says the vaccine will be of great benefit to the NHS and all immunization services, and ultimately to patients.
He noted that the vaccine will most likely be given to people who received a flu shot before the pandemic, including those over 65 and those with long-term health conditions, the report said.